Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients

OBJECTIVE: The impact of the M184V/I mutation on the virological failure (VF) rate in HIV-positive patients with suppressed viremia switching to an abacavir/lamivudine/dolutegravir regimen has been poorly evaluated. METHOD: This is an observational study from 5 European HIV cohorts among treatment-e...

Descripción completa

Detalles Bibliográficos
Autores principales: Olearo, Flaminia, Nguyen, Huyen, Bonnet, Fabrice, Yerly, Sabine, Wandeler, Gilles, Stoeckle, Marcel, Cavassini, Matthias, Scherrer, Alexandra, Costagiola, Dominique, Schmid, Patrick, Günthard, Huldrych F, Bernasconi, Enos, Boeni, Jürg, D’arminio Monforte, Antonella, Zazzi, Maurizio, Rossetti, Barbara, Neau, Didier, Bellecave, Pantxika, Rijnders, Bart, Reiss, Peter, Wit, Ferdinand, Kouyos, Roger, Calmy, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778427/
https://www.ncbi.nlm.nih.gov/pubmed/31660328
http://dx.doi.org/10.1093/ofid/ofz330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778427/
https://www.ncbi.nlm.nih.gov/pubmed/31660328
http://dx.doi.org/10.1093/ofid/ofz330

Ejemplares similares